Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASA + pseudoephedrine for pain and nasal congestion in common cold
2009-011355-46Phase 3Completed
- Sponsor
- Bayer Consumer Health
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aspirin and pseudoephedrine in Viral Upper Respiratory Infection and nasopharyngitis (4 arms), sponsored by Bayer Consumer Health. Primary endpoints: Nasal airflow conductance AUC0-4h and Pain and nasal congestion efficacy over initial 4 hours after first dose. Started Jun 2009; status: completed.
02
Drugs
aspirinpseudoephedrine
03
Conditions
Viral Upper Respiratory Infectionnasopharyngitis
Beyond the preview
Go deeper on 2009-011355-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011355-46.